mementor DE
mementor — health innovation for life
mementor develops and distributes digital medical products in sleep medicine to provide fast and easy access to evidence-based therapies. Founded in Switzerland in 2014 and headquartered in Leipzig since 2020, mementor creates "apps on prescription" that address gaps in conventional care and enable patients to access effective treatments.
The company emphasizes high scientific standards, data protection, and patient safety. mementor is certified for information security (DIN EN ISO/IEC 27001) and quality management for medical devices (DIN EN ISO 13485).
Products and partnership
Notable products include somnio, an approved prescription digital health application (DiGA) for treating insomnia based on cognitive behavioral therapy for insomnia (CBT-I). Clinical effectiveness is supported by randomized controlled trials. mementor also develops other digital therapies such as actensio for hypertension.
Since 02.08.2022 mementor DE operates as a business unit of ResMed in Germany, combining expertise to expand access to digital sleep medicine.